← Back
$CNTA All transactions

Centessa Pharmaceuticals plc

A

$ Value

$0

Shares

165,000

Price

$0

Filed

Jun 3

Insider

Name

Deferiere Raphael

Title

Chief Accounting Officer

CIK

0002071320

Roles

Officer

Transaction Details

Transaction Date

2025-06-02

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

165,000

Footnotes

25% of the shares subject to such option shall vest and become exercisable on June 2, 2026 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments on the first day of each month thereafter. | The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Filing Info

Accession No.

0001847903-25-000086

Form Type

4

Issuer CIK

0001847903

Deferiere Raphael's History

Date Ticker Type Value
2026-02-02 CNTA A $0
2026-02-02 CNTA A $0
2025-06-02 CNTA A $0

Other Insiders at CNTA (90d)

Insider Bought Sold Last
Weinhoff Gregory M
Chief Business Officer
$2.6M 2026-03-26
Crowley John J
Chief Financial Officer
2026-02-02
Kanes Stephen
Chief Medical Officer
2026-02-02
Anderson Karen M.
Chief People Officer
$6.5M 2026-03-26
HUSSAIN IQBAL J
Chief Legal Officer
$1.0M 2026-02-02
Bush Tia L
Chief Technology & Quality Ofc
2026-02-02
Deferiere Raphael
Chief Accounting Officer
2026-02-02
Accardi Mario Alberto
Chief Executive Officer
2026-02-02